Abstract:Abstract We report here a novel, high analytical sensitivity multiplexed-qPCR assay for monitoring human and mouse-specific circulating cell-free DNA (cfDNA) using only 15 microliters of blood harvested from patient-derived xenograft (PDX) mice. PDX tumors maintained in murine models are commonly employed to study the biology and drug sensitivity of patient tumors. Our multiplexed qPCR assay incorporates both human and mouse multi-copy PCR amplifications targets in a single qPCR reaction. The multiplex also includes an internal synthetic DNA positive control to monitor accuracy of PCR amplification. All three targets are quantitated by monitoring three fluorophores in a single qPCR reaction. In PDX mice, the implanted human tumor sheds DNA as circulating tumor DNA (human ctDNA). Select metastatic tumors also shed human circulating tumor cells (CTCs) into the mouse’s blood that also can be detected with our assay. Our qPCR assay utilizes an Alu retrotransposon sequence, present at thousands of copies per human genome, to detect and quantitate human ctDNA, and a mouse specific multi-copy target to detect mouse cfDNA in plasma harvested from PDX mice. These high copy, repetitive elements are ideally suited for qPCR targets to quantitate circulating-tumor DNA, which is predominately in low abundance. The low detection limits of the assay (below 1pg/µL of human DNA extracted from mouse plasma) allows for longitudinal studies of mice, as the volume of blood required is minimal (as low as 15 µL) and can be repeatedly collected from live mice without the need for a terminal bleed. With the assay quantitating both human ctDNA and mouse cfDNA, normalization of the amount of tumor DNA can be calculated, allowing for more reliable tracking of the tumor growth in the mouse model. Furthermore, CTC DNA had higher measurable concentrations in the peripheral blood of both invasive TNBC PDX models compared to cfDNA concentrations. We have tested this assay successfully in mice that contain various tumor burdens (CRC, prostrate, SCLC, and TNBC). Data will be presented to show the relative amounts of human DNA present in these mice. The assay also accurately predicted the success or failure of the initial tumor engraftment of a patient tumor in a mouse—this can be used to reduce cost by eliminating unsuccessful grafts, without waiting for months to observe if the tumor grew or not. This innovative assay provides a relatively quick, economic, and easy method to monitor ongoing response to therapy. Citation Format: Sudhir K. Sinha, Hiromi Brown, Andrew Loftus, Margarite D. Matossian, Bridgette M. Collins-Burow, Matthew E. Burow. Development of a qPCR cfDNA analysis method for the assessment of tumor burden and metastatic status in live PDX mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1077.

An Efficient Probe-Based Quantitative PCR Assay Targeting Human-Specific DNA in ST6GALNAC3 for the Quantification of Human Cells in Preclinical Animal Models

Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems

Human Genome-Specific Real-Time PCR Method for Sensitive Detection and Reproducible Quantitation of Human Cells in Mice

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues

Study on Amplification of the Nucleotide Sequences Homologous to GBV-C from the DNAs of MT2 and HeLa Cells and the PBMC DNAs of Human and Chimpanzee

A new reliable and sensitive nested PCR assay based on the human SRY gene for detection of interspecific chimeras

In Silico Cancer Cell Versus Stroma Cellularity Index Computed from Species-Specific Human and Mouse Transcriptome of Xenograft Models: Towards Accurate Stroma Targeting Therapy Assessment

A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model

TqPCR: A Touchdown Qpcr Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green Qpcr.

Advantages of q-PCR as a method of screening for gene targeting in mammalian cells using conventional and whole BAC-based constructs

[Cloning of splicing variants of alpha1,3-galactosyltransferase cDNA of Chinese Banna Minipig inbred line and its expression in human cells]

A New Intronic Quantitative PCR Method Led to the Discovery of Transformation from Human Ascites to Murine Malignancy in a Mouse Model

Accurate Nucleic Acid Quantification in a Single Sample Tube Without the Need for Calibration.

Highly Specific Quantification of Mrna Mutation in Single Cells Based on RNase H Cleavage-Assisted Reverse Transcription (RT)-PCR

Establishment of a humanized ST6GAL1 mouse model for influenza research

Using A Nano-Flare Probe to Detect Rna in Live Donor Cells Prior to Somatic Cell Nuclear Transfer

A Novel Universal Primer Multiplex Real-Time PCR (UP-M-rtPCR) Approach for Specific Identification and Quantitation of Cat, Dog, Fox, and Mink Fractions Using Nuclear DNA Sequences

Mitochondrial DNA as a target for analyzing the biodistribution of cell therapy products

A Selected Pre-Amplification Strategy for Genetic Analysis Using Limited DNA Targets

Abstract 1077: Development of a qPCR cfDNA analysis method for the assessment of tumor burden and metastatic status in live PDX mice

A Custom qPCR Assay to Simultaneously Quantify Human and Microbial DNA